NCT04280926 - Use of High Sensitivity Cardiac Troponin in Ruling Out Emergency Patients with Acute Myocardial Injury and Infarction | Biotech Hunter

Enrollment

1,000

Participants

Timeline

Start Date

October 13, 2020

Primary Completion Date

October 13, 2021

Study Completion Date

October 13, 2024

Conditions

Acute Myocardial InfarctionAcute Coronary Syndrome

Interventions

DIAGNOSTIC_TEST

Cardiac Troponin Testing

Fresh serum or lithium heparin plasma samples will be measured with the Atellica IM TnIH assay (Siemens Heatlhineers).

Trial Locations (1)

Hennepin Healthcare Research Institute / Hennepin County Medical Center, Minneapolis